Aktie A3CSCN BLACK BIRD BIOTECH, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Black Bird Biotech, Inc.

Aktien

A3CSCN

US09183V1017

BBBT

Markt geschlossen - OTC Markets
Andere Börsenplätze
 16:07:37 14.05.2024 		% 5 Tage % 1. Jan.
0.00015 USD -25.00% Intraday Chart für Black Bird Biotech, Inc. +100.00% +100.00%
16.04. Black Bird Biotech, Inc. ernennt Nelson Grist zum neuen CEO CI
16.04. Black Bird Biotech, Inc. ernennt Nelson Grist zum künftigen Mitglied des Verwaltungsrats CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Black Bird Biotech Announces New CEO; Provides Commentary on Refreshed Path
Black Bird Biotech, Inc. Appoints Nelson Grist as New CEO
Black Bird Biotech, Inc. Appoints Nelson Grist as Its Future Member of Its Board of Directors
Black Bird Biotech : Changes in Control - Form 8-K
Black Bird Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Black Bird Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Black Bird Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
BLACK BIRD BIOTECH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Black Bird Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Black Bird Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Black Bird Biotech, Inc. Auditor Raises 'Going Concern' Doubt
Black Bird Biotech : Material Agreement - Form 8-K
BLACK BIRD BIOTECH, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
Black Bird Biotech, Inc. announced that it expects to receive $5 million in funding from Mast Hill Management, LLC
Black Bird Biotech Secures Distribution Agreement for Its MiteXstream Biopesticide
XCPCNL Business Services announces that it has been hired by Black Bird Biotech to Boost Bee Tested, Bee Safe MiteXstream Biopesticide Sales Within Cannabis Industry
Black Bird Biotech Hires XCPCNL Business Services Corporation to Boost Bee Tested, Bee Safe Mitexstream Biopesticide Sales Within Cannabis Industry
BLACK BIRD BIOTECH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Black Bird Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Black Bird Biotech To Formally Test MiteXstream Biopesticide for Capacity to Boost Plant Growth, Fruit Production, In Common Agricultural Crops
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CSCN Aktie
  4. Nachrichten Black Bird Biotech, Inc.
  5. Andere Sprachen